• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥美拉唑对人体胃酸分泌及血浆胃泌素的影响。

Effect of omeprazole on gastric acid secretion and plasma gastrin in man.

作者信息

Olbe L, Cederberg C, Lind T, Olausson M

机构信息

Dept. of Surgery, Sahlgrenska Hospital, Gothenburg, Sweden.

出版信息

Scand J Gastroenterol Suppl. 1989;166:27-32; discussion 41-2. doi: 10.3109/00365528909091240.

DOI:10.3109/00365528909091240
PMID:2690329
Abstract

Single doses of omeprazole inhibit pentagastrin-stimulated gastric acid secretion and almost complete inhibition can be achieved for 4-6 hours with a single dose of 80 mg. Acid secretion then slowly returns and reaches normal levels after 3-4 days. Omeprazole also dose-dependently inhibits basal acid secretion as well as acid secretion stimulated with histamine, peptone and modified sham feeding, with similar efficiency. During repeated once-daily dosing with an enteric-coated granule capsule formulation, inhibition of acid secretion increased initially, and stabilized within about 4 days. Dose-response studies in patients with duodenal ulcers and healthy subjects have shown that 20-40 mg/day results in a peak reduction (80-100%) of pentagastrin-stimulated acid secretion 6 hours after dose. Studies of 24-hour intragastric acidity in duodenal ulcer patients have shown that 4 weeks of treatment with omeprazole, 20 mg once daily, resulted in a reduction of median intragastric acidity by 97%, which was superior to the 57% median reduction achieved with ranitidine, 150 mg b.d., for 4 weeks in the same patients. During omeprazole treatment, fasting plasma gastrin increased in relation to the degree of inhibition of acid secretion. After discontinuation of treatment, plasma gastrin normalized. Treatment with omeprazole, 20 mg, increased 24-hour plasma gastrin to the same extent as after highly selective vagotomy. Long-term treatment with omeprazole, 20-40 mg, for up to 2 years has not been associated with any progressive rise in fasting plasma gastrin.

摘要

单次服用奥美拉唑可抑制五肽胃泌素刺激的胃酸分泌,单次服用80mg时,4-6小时内几乎可实现完全抑制。随后胃酸分泌缓慢恢复,3-4天后达到正常水平。奥美拉唑还可剂量依赖性地抑制基础胃酸分泌以及组胺、蛋白胨和改良假饲刺激的胃酸分泌,且效率相似。在每日一次重复服用肠溶颗粒胶囊制剂期间,胃酸分泌的抑制作用最初增强,并在约4天内稳定下来。十二指肠溃疡患者和健康受试者的剂量反应研究表明,每天服用20-40mg可使五肽胃泌素刺激的胃酸分泌在服药后6小时达到最大减少量(80-100%)。对十二指肠溃疡患者24小时胃内酸度的研究表明,每日一次服用20mg奥美拉唑治疗4周,可使胃内酸度中位数降低97%,优于同一患者每日两次服用150mg雷尼替丁治疗4周所达到的57%的中位数降低幅度。在奥美拉唑治疗期间,空腹血浆胃泌素随胃酸分泌抑制程度的增加而升高。停药后,血浆胃泌素恢复正常。服用20mg奥美拉唑治疗可使24小时血浆胃泌素升高至与高选择性迷走神经切断术后相同的程度。长期服用20-40mg奥美拉唑长达2年,空腹血浆胃泌素未出现任何进行性升高。

相似文献

1
Effect of omeprazole on gastric acid secretion and plasma gastrin in man.奥美拉唑对人体胃酸分泌及血浆胃泌素的影响。
Scand J Gastroenterol Suppl. 1989;166:27-32; discussion 41-2. doi: 10.3109/00365528909091240.
2
Effect of omeprazole on gastric acid secretion and plasma gastrin.
J Gastroenterol Hepatol. 1989;4 Suppl 2:19-25.
3
24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients.十二指肠溃疡患者接受奥美拉唑治疗及近端胃迷走神经切断术后的24小时胃内酸度和血浆胃泌素水平
Gastroenterology. 1990 Dec;99(6):1593-8. doi: 10.1016/0016-5085(90)90462-a.
4
Effect of omeprazole on gastric acid secretion in man.奥美拉唑对人体胃酸分泌的影响。
Scand J Gastroenterol Suppl. 1986;118:105-7. doi: 10.3109/00365528609090908.
5
Omeprazole in elderly duodenal ulcer patients: relationship between reduction in gastric acid secretion and fasting plasma gastrin.老年十二指肠溃疡患者使用奥美拉唑:胃酸分泌减少与空腹血浆胃泌素之间的关系
Eur J Clin Pharmacol. 1991;40(6):557-60. doi: 10.1007/BF00279969.
6
Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment.奥美拉唑治疗期间胃酸分泌减少与血浆胃泌素浓度之间的关系。
Scand J Gastroenterol. 1988 Dec;23(10):1259-66. doi: 10.3109/00365528809090202.
7
Prolonged inhibition of acid secretion causes hypergastrinaemia without altering pH inhibition of gastrin release in humans.长期抑制胃酸分泌会导致高胃泌素血症,而不会改变人体中胃泌素释放的pH抑制作用。
Aliment Pharmacol Ther. 1990 Oct;4(5):443-56. doi: 10.1111/j.1365-2036.1990.tb00491.x.
8
Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.口服高剂量雷尼替丁或奥美拉唑的抑酸作用比较。
Aliment Pharmacol Ther. 1994 Apr;8(2):193-201. doi: 10.1111/j.1365-2036.1994.tb00278.x.
9
Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole.雷尼替丁或奥美拉唑治疗前及治疗期间的24小时胃内酸度和血浆胃泌素浓度。
Aliment Pharmacol Ther. 1987 Jun;1(3):239-51. doi: 10.1111/j.1365-2036.1987.tb00623.x.
10
Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients.十二指肠溃疡患者短期使用奥美拉唑和雷尼替丁治疗期间的胃酸分泌及血浆胃泌素水平
Hepatogastroenterology. 1992 Aug;39(4):366-70.

引用本文的文献

1
Inhibition of gastric acid secretion with omeprazole affects fish specific dynamic action and growth rate: Implications for the development of phenotypic stomach loss.用奥美拉唑抑制胃酸分泌会影响鱼类的特殊动力作用和生长速率:对表型胃丧失发展的启示。
Front Physiol. 2022 Sep 27;13:966447. doi: 10.3389/fphys.2022.966447. eCollection 2022.
2
Risk of fracture and pneumonia from acid suppressive drugs.抑酸药物导致骨折和肺炎的风险。
World J Methodol. 2011 Sep 26;1(1):15-21. doi: 10.5662/wjm.v1.i1.15.
3
Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.
抑酸药物的使用与骨折风险:一项观察性研究的荟萃分析。
Ann Fam Med. 2011 May-Jun;9(3):257-67. doi: 10.1370/afm.1243.
4
Treatment of gastroesophageal reflux disease.胃食管反流病的治疗
Pharm World Sci. 2005 Dec;27(6):432-5. doi: 10.1007/s11096-005-4798-7.
5
Cough threshold in reflux oesophagitis: influence of acid and of laryngeal and oesophageal damage.反流性食管炎的咳嗽阈值:酸以及喉和食管损伤的影响。
Gut. 2000 Jun;46(6):762-7. doi: 10.1136/gut.46.6.762.
6
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.胃食管反流病治疗中的药代动力学优化
Clin Pharmacokinet. 1996 Nov;31(5):386-406. doi: 10.2165/00003088-199631050-00005.
7
Omeprazole causes delay in gastric emptying of digestible meals.奥美拉唑会导致可消化食物的胃排空延迟。
Dig Dis Sci. 1996 Mar;41(3):469-74. doi: 10.1007/BF02282320.
8
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole.奥美拉唑治疗门诊患者期间的十二指肠细菌过度生长
Gut. 1994 Jan;35(1):23-6. doi: 10.1136/gut.35.1.23.
9
Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.
Dig Dis Sci. 1992 Jun;37(6):865-74. doi: 10.1007/BF01300384.
10
Progress with proton pump inhibition.质子泵抑制作用的进展
Yale J Biol Med. 1992 Nov-Dec;65(6):649-57;discussion 689-92.